Bicycle Therapeutics

Bicycle Therapeutics

BCYC· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -49.4% in FY2025

Kevin Lee, Ph.D., MBA is the CEO of Bicycle Therapeutics and was paid $6.3M in FY2025 (Dec), up 31%.

Pay$100 in the stock at the end of FY21 → $19
CEO pay is from each Bicycle Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Kevin Lee, Ph.D., MBAFY2025
  2. 2Michael Skynner, Ph.D.FY2025
  3. 3Alistair MilnesFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Bicycle Therapeutics paid its 3 named executives $11.0M in total in FY2025 (Dec). CEO Kevin Lee, Ph.D., MBA was paid $6.3M of that.

Name
Kevin Lee, Ph.D., MBAChief Executive OfficerNot disclosed
Michael Skynner, Ph.D.Chief Scientific OfficerNot disclosedNot disclosed
Alistair MilnesChief Corporate Development Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2024 (Dec) proxy of Bicycle Therapeutics names 19 peer companies for pay. Among Bicycle Therapeutics and these peers, CEO pay was the lowest of 9 and total shareholder return was 6th highest of 9.

9th highest of 9in Bicycle Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:

$4.9M$18.8M

6th highest of 9in Bicycle Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:

$47$271

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Felix BakerChair · 1 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 22, 2026FY2025
Annual report10-KMar 17, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 15, 2024FY2023
Annual report10-KFeb 20, 2024FY2023